日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer

阿特珠单抗联合FOLFOX方案治疗III期错配修复缺陷型结肠癌

Sinicrope, Frank A; Ou, Fang-Shu; Arnold, Dirk; Peters, Walter R; Behrens, Robert J; Lieu, Christopher H; Matin, Khalid; Cohen, Deirdre J; Potter, Samara L; Nixon, Andrew B; Kottschade, Lisa A; Kathol, Emily; Frankel, Wendy L; Shergill, Ardaman; Hsu, Dennis; Reinacher-Schick, Anke; Mehan, Paul; Gold, Philip J; Khalil, Maged F; Zemla, Tyler; Gatten, Clare; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)

帕唑帕尼与安慰剂治疗晚期胰外神经内分泌肿瘤患者的随机 II 期试验(Alliance A021202)

Bergsland, Emily K; Geyer, Susan; Asmis, Timothy R; Behr, Spencer C; Kuebler, J Philip; Kumthekar, Priya; Mazza, Gina; Maitland, Michael L; Niedzwiecki, Donna; Nixon, Andrew B; Schwartz, Lawrence Howard; Strosberg, Jonathan R; Venook, Alan P; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

针对补体因子 H 的抗体 GT103 在难治性非小细胞肺癌中的应用:一项 1b 期剂量递增试验

Clarke Jeffrey M, Simon George R, Mamdani Hirva, Gu Lin, Herndon James E 2nd, Stinchcombe Thomas E, Ready Neal, Crawford Jeffrey, Sonpavde Guru, Balevic Stephen, Nixon Andrew B, Campa Michael, Gottlin Elizabeth B, Li Huihua, Saxena Ruchi, He You Wen, Antonia Scott, Patz Edward F Jr

Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)

贝伐珠单抗联合每周一次阿奈妥单抗或每周一次紫杉醇治疗铂类耐药/难治性高级别卵巢癌的随机 II 期研究(NCI 试验)

Alqaisi, Husam A; Cohn, David E; Chern, Jing-Yi; Duska, Linda R; Jewell, Andrea; Corr, Bradley R; Winer, Ira Seth; Girda, Eugenia; Crispens, Marta A; Dhani, Neesha C; Madariaga, Ainhoa; Grant, Robert C; Malaguti, Matthew; Lee, Crystal; Bowering, Valerie; Wong, Horace; Poothullil, Andrew; Speers, Vanessa; Wang, Lisa; Bedard, Philippe L; Brady, John C; Nixon, Andrew B; Chen, Li; O'Connor, Claire; Zamboni, William; McKee, Tawyna; Moscow, Jeffrey A; Oza, Amit M; Lheureux, Stephanie

Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab

对接受多西他赛/泼尼松联合或不联合贝伐珠单抗治疗的转移性去势抵抗性前列腺癌男性患者循环血浆生物标志物的预后和预测分析

Nixon, Andrew B; Liu, Yingmiao; Yang, Qian; Luo, Bin; Starr, Mark D; Brady, John C; Kelly, Wm Kevin; Beltran, Himisha; Morris, Michael J; George, Daniel J; Armstrong, Andrew J; Halabi, Susan

Pilot Exploratory Analysis of Serum Gonadal Hormones, Inflammatory Proteins, and Intracerebral Hemorrhage Outcomes

血清性腺激素、炎症蛋白与脑出血结局的初步探索性分析

Ng, Yisi; Qi, Wenjing; Covington, Anna; Boone, Bobby 4th; Kuhn, Cynthia; Nixon, Andrew B; King, Nicolas Kon Kam; Kranz, Peter F; Christianson, Thomas; Thakkar, Roshni; Laskowitz, Daniel T; Sasannejad, Cina; Bhima, Miran; Krishnamoorthy, Vijay; Shah, Shreyansh; Wagner, Amy K; James, Michael L

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations

一项针对携带FGFR改变的转移性或不可切除性结直肠癌患者的pemigatinib II期多中心单臂研究

Wheless, Margaret C; Zemla, Tyler J; Hubbard, Joleen M; Strickler, John H; Gbolahan, Olumide B; Wilson, Luke; Waechter, Blake; Ou, Fang-Shu; Nixon, Andrew B; Bekaii-Saab, Tanios S; Ciombor, Kristen K

Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants

健康参与者血管组生物标志物生物学变异性随时间变化的特征分析

Liu, Yingmiao; Li, Jiatong; Lyu, Jing; Howard, Lauren E; Sibley, Alexander B; Starr, Mark D; Brady, John C; Arrowood, Christy; Kohn, Elise C; Ivy, S Percy; Hurwitz, Herbert I; Abbruzzese, James L; Owzar, Kouros; Nixon, Andrew B

Novel treatment-specific causal biomarkers for colorectal cancer by omics integration

通过组学整合发现结直肠癌新型治疗特异性因果生物标志物

Yazdani, Akram; Yazdani, Azam; Mendez-Giraldez, Raul; Pillonetto, Gianluigi; Samiei, Esmat; Hadi, Reza; Lenz, Heinz-Josef; Venook, Alan P; Samiei, Ahmad; Nixon, Andrew B; Lucci, Joseph A; Kopetz, Scott; Bertagnolli, Monica M; Innocenti, Federico

A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers

一项初步研究,旨在调查帕博利珠单抗对新诊断的苗勒氏管癌肿瘤免疫表型的影响

Gaillard, Stéphanie L; Broadwater, Gloria; Berchuck, Andrew; Andrews, William S; Havrilesky, Laura J; Davidson, Brittany A; Previs, Rebecca A; Starr, Mark D; Yi, John S; Nixon, Andrew B; Neff, Jadee L; Conejo-Garcia, Jose Ramon; Secord, Angeles Alvarez